Pharmanutra S.p.A. (BIT:PHN)
Italy · Delayed Price · Currency is EUR 72.20
+1.30 (1.83%)
Sep 25, 2026, 5:35 PM CET
Pharmanutra Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Pharmanutra stock has a consensus rating of "Strong Buy" and an average price target of €95.67. The average 1-year stock price forecast is 32.51% higher than the current stock price, while the lowest is €92.00 (+27.42%) and the highest is €102.00 (+41.27%).
Price Target: €95.67 (+32.51%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Pharmanutra stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | May '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TP ICAP MIDCAP | TP ICAP MIDCAP | Buy Reiterates €92.00 | Buy | Reiterates | €92.00 | +27.42% | Sep 15, 2026 |
| Intermonte | Intermonte | Buy Reiterates €98.00 → €102.00 | Buy | Reiterates | €98.00 → €102.00 | +41.27% | Sep 14, 2026 |
| Berenberg Bank | Berenberg Bank | Buy Maintains €85.00 → €93.00 | Buy | Maintains | €85.00 → €93.00 | +28.81% | May 13, 2026 |
Financial Forecast
Revenue This Year
156.37M
from 132.16M
Increased by 18.32%
Revenue Next Year
183.20M
from 156.37M
Increased by 17.16%
EPS This Year
2.47
from 2.09
Increased by 18.18%
EPS Next Year
3.13
from 2.47
Increased by 26.52%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.